journal club - empagliflozin improves heart failure symptoms
Published 2 years ago • 6.3K plays • Length 4:13Download video MP4
Download video MP3
Similar videos
-
2:07
fda approves empagliflozin use for heart failure despite contrary results of trials
-
5:10
empagliflozin retains benefits in ‘true’ hfpef patients
-
5:20
empagliflozin safe in acute hf, improves ‘clinical benefit’ over time
-
48:02
webinar | jacc: heart failure october virtual journal club
-
50:31
webinar | jacc: heart failure december virtual journal club - discussion on the stand-up ahf study
-
11:43
the truth about jardiance for weight loss: does jardiance help lose weight | dr. dan obesity expert
-
6:50
new hope for heart failure patients- a gamechanger arrives
-
12:03
jardiance
-
1:01
hmvjc minute #33 - empagliflozin for heart failure and preserved ef: september 4, 2021
-
6:28
emperor-reduced: empagliflozin benefits in hf patients irrespective of diabetes | milton packer
-
10:31
jardiance for heart failure and diabetes: an in-depth summary
-
54:13
jacc: heart failure journal club discussion | splanchnic nerve block
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
7:35
cardiac & renal outcomes with efpeglenatide in diabetes (amplitude-o) | nejm | med journal club
-
5:36
acc 22: results from the empulse study - empagliflozin proves beneficial for patients with hf
-
5:21
empulse: the ‘missing link’ for empagliflozin in heart failure | adriaan voors
-
30:29
heart failure spotlight: jardiance® (empagliflozin) tablets: the impact of empa-reg outcome
-
3:21
how does sglt2 inhibition improve heart failure?
-
51:05
jacc: heart failure journal club | june 18, 2020
-
7:24
empulse trial. empagliflozin in acute heart failure. aha2021
-
58:37
emory cardiology friday fellows journal club 10-07-2022
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf